Effects of isomaltodextrin (IMD) on glucose, insulin, glucagon and incretins: Comparison with maltodextrin in healthy volunteers
- Conditions
- Type 2 diabetes, obesity
- Registration Number
- JPRN-UMIN000025308
- Lead Sponsor
- Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 12
Not provided
1. Individuals receiving anti-diabetic drugs 2. Individuals with renal impairment 3. Individuals with hepatic impairment 4. Individuals with history of cerebrovascular disorders and/or ischemic heart diseases 5. Individuals with heart failure (NYHA I-IV) 6. Individuals with history of GI surgery 7. Individuals with excess alcohol consumption 8. Individuals with low Hb values: male, < 13.0g/dL and female 12.5 g/dL 9. Individuals who cannot follow orders from chief investigator or sub investigator 10. Individuals enrolled in other clinical trials 11. Pregnant individuals or those suspected of pregnancy 12. Individuals who are judged as inappropriate to be enrolled in this trials by chief investigator or sub investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method